Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Public ClinicalTrials.gov record NCT06315751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind, Placebo-controlled, Phase 2b, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients With Tourette Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the efficacy and safety of gemlapodect (NOE-105) on reducing tics associated with Tourette Syndrome (TS) in adults with TS. Adolescents will be enrolled after a sentinel cohort of adults is complete.
Study identification
- NCT ID
- NCT06315751
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 164 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2024 (Actual)
- Primary completion
- Jun 2026 (Estimated)
- Completion
- Jun 2026 (Estimated)
- Last update posted
- Mar 9, 2026
2024 – 2026
United States locations
- U.S. sites
- 31
- U.S. states
- 17
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Noema TTS-201 Site #81 | Sun City | Arizona | 85351 | — |
| Noema TTS-201 Site #95 | Bellflower | California | 90706 | — |
| Noema TTS-201 Site #75 | Glendale | California | 91203 | — |
| Noema TTS-201 Site #59 | San Rafael | California | 94903 | — |
| Noema TTS-201 Site #21 | Walnut Creek | California | 94596 | — |
| Noema TTS-201 Site #54 | Gulf Breeze | Florida | 32561 | — |
| Noema TTS-201 Site #05 | Hialeah | Florida | 33013 | — |
| Noema TTS-201 Site #97 | Jensen Beach | Florida | 34957 | — |
| Noema TTS-201 Site #71 | Largo | Florida | 33777 | — |
| Noema TTS-201 Site #44 | Maitland | Florida | 32751 | — |
| Noema TTS-201 Site # 74 | Miami | Florida | 33136 | — |
| Noema TTS-201 Site #56 | Miami Lakes | Florida | 33016 | — |
| Noema TTS-201 Site #61 | Orlando | Florida | 32802 | — |
| Noema TTS-201 Site #79 | Atlanta | Georgia | 30318 | — |
| Noema TTS-201 Site #87 | Peachtree Corners | Georgia | 30071 | — |
| Noema TTS-201 Site #55 | Boston | Massachusetts | 02114 | — |
| Noema TTS-201 Site #51 | Ann Arbor | Michigan | 48105 | — |
| Noema TTS-201 Site #96 | Saint Charles | Missouri | 63304 | — |
| Noema TTS-201 Site #93 | Lincoln | Nebraska | 68526 | — |
| NOema TTS-201 Site #19 | New York | New York | 10003 | — |
| Noema TTS-201 Site #03 | Stony Brook | New York | 11794 | — |
| Noema TTS-201 Site #57 | Charlotte | North Carolina | 28211 | — |
| Noema TTS-201 Site #58 | Middleburg Heights | Ohio | 44130 | — |
| Noema TTS-201 Site #73 | North Charleston | South Carolina | 29405 | — |
| Noema TTS-201 Site #98 | Nashville | Tennessee | 37203 | — |
| Noema TTS-201 Site #42 | Dallas | Texas | 75243 | — |
| Noema TTS-201 Site #22 | Fort Worth | Texas | 76104 | — |
| Noema TTS-201 Site #94 | San Antonio | Texas | 78249 | — |
| Noema TTS-201 Site #45 | Orem | Utah | 84097 | — |
| Noema TTS-201 Site #18 | Petersburg | Virginia | 23805 | — |
| Noema TTS-201 Site #50 | Bellevue | Washington | 98007 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06315751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06315751 live on ClinicalTrials.gov.